Blast Crisis: Clinical Trials

2 trials for Blast Crisis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Blast Crisis: new trials by email Literature Review of Blast Crisis trials Research Report on Blast Crisis

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant
moxifloxacin hydrochloride, Placebo - Breast Cancer, Chronic Myeloproliferative Disorders
Phase 3TerminatedOHSU Knight Cancer Institute2402006-05-012017-05-09
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
mycophenolate mofetil, placebo - Cancer
Phase 3TerminatedMartin, Paul1512004-05-012013-05-03

Narrower conditions

Breast Neoplasms (2)  ·  Burkitt Lymphoma (2)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Leukemia, Myeloid, Accelerated Phase (2)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2)  ·  Leukemia, Myeloid, Chronic-Phase (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Leukemia, Neutrophilic, Chronic (2)  ·  Lymphoma, B-Cell, Marginal Zone (2)  ·  Lymphoma, Follicular (2)  ·  Lymphoma, Large B-Cell, Diffuse (2)  ·  Lymphoma, Large-Cell, Immunoblastic (2)  ·  Lymphoma, Mantle-Cell (2)

Broader conditions

Adnexal Diseases (2)  ·  Blood Protein Disorders (2)  ·  Bone Marrow Diseases (2)  ·  Breast Diseases (2)  ·  Carcinogenesis (2)  ·  Carcinoma (2)  ·  Cardiovascular Diseases (2)  ·  Cell Transformation, Neoplastic (2)  ·  Chronic Disease (2)  ·  DNA Virus Infections (2)  ·  Disease Attributes (2)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Epstein-Barr Virus Infections (2)  ·  Female Urogenital Diseases (2)

Interventions

Moxifloxacin (1)  ·  Mycophenolic Acid (1)

Sponsors

Martin, Paul (1)  ·  OHSU Knight Cancer Institute (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

Joseph Bubalo, PharmD, BCPS, BCOP (1)  ·  Paul J. Martin, MD (1)

Results publications

PMID 19270260

NIH funding

P30CA069533 (1)